Jun 7 |
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
|
Jun 7 |
Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth
|
Jun 6 |
Denali: Cash, Big Pharma Partnerships And High Potential For MPS-II Do Not Warrant A Buy
|
Jun 6 |
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
|
Jun 4 |
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
|
Jun 3 |
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
|
May 13 |
Denali Therapeutics: MPS Treatment Program Continues With End Of 2024 Data
|
May 12 |
Cantor picks 14 undervalued biotech stocks worth a second look
|
May 11 |
The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
|
May 9 |
Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
|